✦ LIBER ✦

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

✍ Scribed by R. Asola; H. Huhtala; K. Holli

Publisher: Springer US
Year: 2006
Tongue: English
Weight: 134 KB
Volume: 100
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-006-9224-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Associations of physical activity with q

Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study

✍ Jeanne S. Mandelblatt; Gheorghe Luta; Marilyn L. Kwan; Solomon B. Makgoeng; Isaa 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 188 KB

Nuclear karyopherin α2 expression predic

Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

✍ Oleg Gluz; Peter Wild; Robert Meiler; Raihana Diallo-Danebrock; Evelyn Ting; Svj 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 253 KB 👁 1 views

## Abstract Intensive lymph node involvement indicates poor prognosis in breast cancer patients. The significance of other molecular prognostic factors in this subgroup is unclear. Karyopherin α2 (KPNA2) has been reported as an important factor of tumorgenesis and progression of breast cancer. The

Quality of life during chemotherapy in p

Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer

✍ Bengt Glimelius; Katarina Hoffman; Wilhelm Graf; Lars Påhlman; Per-Olow Sjödén 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Health-related quality of life during th

✍ Marianne Ahlner Elmqvist; Marit S. Jordhøy; Kristin Bjordal; Stein Kaasa; Magnus 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 154 KB

Serum elimination half-life of tamoxifen

Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer

✍ Dick Vos; Peter H. Th. J. Slee; Derek Stevenson; Ray J. Briggs 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 291 KB

Mitozantrone and prednimustine in the tr

Mitozantrone and prednimustine in the treatment of advanced breast cancer — a toxic regimen with low activity

✍ M. E. R. O'Brien; D. M. Eccles; S. G. Allen; G. Knight; A. Rodger; U. Chetty; J. 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 274 KB